Fortrea Holdings Inc
NASDAQ:FTRE

  • LAST PRICE
    20.0000
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    18.8000/ 1
  • Ask / Lots
    20.5800/ 2
  • Open / Previous Close
    --- / 20.0000
  • Day Range
    ---
  • 52 Week Range
    18.0700
    41.0200
  • Volume
    ---

Search Criteria

Click on magnifying glass icon to search

CompanyCountrySymbol

Charts

Price Comparison Graph. See accessible table below
Data delayed at least 15 minutes.

Biotechnology Industry Peers

CompanyMarket CapP/E Ratio (TTM)EPS Growth (5yr)
FTRE
Fortrea Holdings Inc
1.8B
-7.8x
---
ALKS
Alkermes Plc
4.6B
10.5x
---
PIII
P3 Health Partners Inc
138.2M
-0.7x
---
EXEL
Exelixis Inc
7.4B
22.2x
-21.77%
NVAX
Novavax Inc
2.0B
-4.6x
---
INCY
Incyte Corp
12.7B
186.9x
+39.11%
As of 2024-10-01

Company Information

Fortrea Holdings Inc. is a global contract research organization (CRO), which provides clinical development solutions to the life sciences industry. The Company is engaged in providing biopharmaceutical product and medical device development services to pharmaceutical, biotechnology and medical device customers. The Company offers customers flexible delivery models that include full service, functional service provider, and hybrid service structures. It provides phase I-IV clinical trial management, clinical pharmacology and consulting services. The Company manages its business through a single segment, Clinical Services, that provides services across the clinical pharmacology and clinical development spectrum. The Company has access to all key markets worldwide through a footprint of primary office locations in five countries (the United States, the United Kingdom, China, India and Singapore) with field operations in other jurisdictions worldwide.

Contact Information

Headquarters
8 Moore DriveDURHAM, NC, United States 27709
Phone
---
Fax
302-636-5454

Executives

Chairman of the Board, Chief Executive Officer
Thomas Pike
Chief Financial Officer
Jill Mcconnell
Chief Operating Officer President - Clinical Services
Mark Morais
Lead Independent Director
R. Andrew Eckert
Director
Machelle Sanders

Ratings

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

Reports

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals

Market Cap
$1.8B
Revenue (TTM)
$2.9B
Shares Outstanding
89.6M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
---
EPS
$-2.56
Book Value
$19.30
P/E Ratio
-7.8x
Price/Sales (TTM)
0.6
Price/Cash Flow (TTM)
---
Operating Margin
-2.96%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Calendar

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.